Ebola vaccine clinical researches start

Ebola vaccine clinical researches start, which is the chance for Ebola virus treatment, will start in the upcoming weeks.

Thousands of experiments of vaccines against Ebola virus, developed by British GSK and American NewLink Genetics, should be available in early 2015, the World Health Organization announced on Saturday.

Deputy GM at NewLink Genetics, Brian Wiley, in his addressing to Canadian journalists, said that clinical researches will be sponsored by the American Ministry of Defense and the international Institute for allergies and infective diseases.

The Ebola virus spot is in the West Africa where so far almost 70% of infected people died from it.

Earlier last week, the World Health Organization announced that the number of the dead in the most dangerous Ebola epidemic so far in the West Africa reached 3.338 people out of 7.178 infected.

The World Health Organization outlines that by early next year there might be 1, 4 million people infected with Ebola. The World Health Organization still has not found efficient treatment or vaccine which would prevent disease spreading.